(Q52889651)

9 May 2018

title

Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma. (English)

1 reference

9 May 2018

1 reference

1 reference

2

1 reference

9 May 2018

author name string

Joycelyn J X Lee

series ordinal

1

1 reference

9 May 2018

Tiffany Tang

series ordinal

3

1 reference

9 May 2018

publication date

12 January 2016

1 reference

9 May 2018

published in

Acta Oncologica

1 reference

9 May 2018

volume

55

1 reference

9 May 2018

issue

4

1 reference

9 May 2018

page(s)

519-520

1 reference

9 May 2018

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

cites work

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1125017

miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1125017

Immune checkpoint blockade in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1125017

Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1125017

T cells from Programmed Death-1 deficient mice respond poorly to Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1125017

CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2015.1125017

10.3109/0284186X.2015.1125017

21 January 2018

Identifiers

DOI

1 reference

9 May 2018

PubMed ID

26754959

1 reference

9 May 2018